The role of circulating tumor DNA in patients with colon cancer

by M. Yu. Fedyanin, E. M. Polyanskaya, S. A. Tjulyandin
Published 2016-10-01

FOLFOXIRI versus FOLFOX or FOLFIRI with targeted therapy in patients with mutant BRAF metastatic colorectal cancer: A systematic review and meta-analysis

by M. Yu. Fedyanin, E. M. Polyanskaya, H. H.-M. Elsnukaeva, A. A. Tryakin, I. A. Pokataev, A. A. Bulanov, S. A. Tjulandin
Published 2020-12-01

Factors associated with the efficiency of maintenance therapy in patients with metastatic colorectal cancer

by M. Yu. Fedyanin, A. A. Tryakin, E. M. Polyanskaya, I. A. Pokataev, O. V. Sheina, N. A. Kozlov, A. M. Strogonova, S. S. Gordeev, D. V. Kuz’michev, V. A. Aliev, I. V. Sagaydak, S. A. Rasulov, S. A. Tyulandin
Published 2016-08-01

FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study

by M. Yu. Fedyanin, E. M. Polyanskaya, I. A. Pokataev, A. A. Tryakin, O. V. Sekhina, D. A. Chekini, Kh.-Kh. M. Elsnukaeva, A. N. Polyakov, I. V. Sagaydak, V. D. Podluzhniy, V. A. Aliev, S. S. Gordeev, D. V. Kuzmichev, Z. Z. Mamedli, S. A. Tjulandin
Published 2019-11-01